OR Spectrum publishes applied and theoretical articles, contributing to Operations Research as a scientific tool. Develops and applies quantitative ...
或频谱(Or Spectrum)是一本由Springer Berlin Heidelberg出版的一本管理科学-运筹学与管理科学学术刊物,主要报道管理科学-运筹学与管理科学相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于1979年,出版周期Quarterly。2021-2022年最新版WOS分区等级:Q3,2023年发布的影响因子为1.4,CiteScore指数4.9,SJR指数0.958。
JCR 影响因子(Impact factor), 5年期影响因子, 即年指数(Immediacy Index), 论文数量, 半衰期, 特征因子(Eigenfactor), 论文影响分值 [科研必备] 专业SCI论文修改服务: ★先修改后付款;☆语言问题免费重修;★24-72小时交稿; ☆正规财务发票;★一分钟下单;☆365日不间断服务期刊全名 or spectrum ...
也就是说,一个期刊的AIS是指这个期刊上的文章在其发表后的5年内的平均影响力。另外,AIS比5-year impact factor更具说服力;例如,Operations Research的5-year impact factor不见得能排进前5,但是AIS仍然是超高的,这代表Operations Research是个极具影响力的期刊(这当然是废话)。 具体参见JCR的官方说明: http://...
Climate shocks to food systems have been thoroughly researched in terms of food security and supply chain management. However, sparse research exists on th
they can emit light in an adjustable spectrum, allowing greater flexibility in the application of AOPs to target different contaminants in water, such as ARBs and ARGs. Third, they have a longer useful life than conventional material lamps, reducing maintenance and replacement costs. Fourth, they...
Constitutive CME is required for plasma membrane protein and lipid turnover, endocytosis of activated growth-factor receptors, low-density lipoprotein and iron-saturated transferrin uptake [48,79,302]. Tau is capable of binding transferrin [276], which binds Fe3+ions prior to clathrin-mediated upta...
Alcohol exposure during development: Impact on the epigenome Fetal alcohol spectrum disorders represent a wide Perkins,Lehmann,Lawrence,... - 《International Journal of Developmental Neuroscience the Official Journal of the International Society for Developmental Neuroscience》 被引量: 108发表: 2013年 Healt...
AS modulation can be achieved by regulating the activity of key splicing factors (broad-spectrum) or by precisely targeting specific isoforms [2]. Multiple small molecular compounds that target splicing factors and affect global splicing have been identified over the years and showed preclinical promise...
(Fig.2). Inhibitors targeting other cell cycle CDKs are currently in clinical trials, and with this progress, the spectrum of tumor targets increases. Two tumor entities with evolving relevance for CDK targeting agents include head and neck squamous cell carcinoma (HNSCC) and glioblastoma ...